[go: up one dir, main page]

HK1161220A - Crystalline forms of a 3-carboxypropyl-aminotetralin compound - Google Patents

Crystalline forms of a 3-carboxypropyl-aminotetralin compound Download PDF

Info

Publication number
HK1161220A
HK1161220A HK12101550.6A HK12101550A HK1161220A HK 1161220 A HK1161220 A HK 1161220A HK 12101550 A HK12101550 A HK 12101550A HK 1161220 A HK1161220 A HK 1161220A
Authority
HK
Hong Kong
Prior art keywords
crystalline solid
solid forms
carboxypropyl
crystalline forms
aminotetralin compound
Prior art date
Application number
HK12101550.6A
Other languages
Chinese (zh)
Inventor
Sean Dalziel
Miroslav Rapta
Original Assignee
Theravance Biopharma R&D Ip Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Biopharma R&D Ip Llc filed Critical Theravance Biopharma R&D Ip Llc
Publication of HK1161220A publication Critical patent/HK1161220A/en

Links

Abstract

The invention provides crystalline solid forms of (S)-4-((2S,3S)-7-carbamoyl-1,1-diethyl-3-methoxy-1,2,3,4-tetrahydronaphthalen-2-ylamino)-2-cyclohexylmethyl-butyric acid. The invention also provides pharmaceutical compositions comprising such crystalline solid forms, methods of using such crystalline solid forms to treat diseases associated with mu opioid receptor activity, and processes useful for preparing such crystalline solid forms.
HK12101550.6A 2008-12-10 2009-12-09 Crystalline forms of a 3-carboxypropyl-aminotetralin compound HK1161220A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61/121,254 2008-12-10

Publications (1)

Publication Number Publication Date
HK1161220A true HK1161220A (en) 2012-08-24

Family

ID=

Similar Documents

Publication Publication Date Title
WO2008001195A3 (en) Novel processes for the preparation of dpp iv inhibitors
WO2009139817A3 (en) Crystalline pharmaceutical and methods of preparation and use thereof
WO2008121348A3 (en) Peripheral opioid receptor antagonists and uses thereof
WO2009111700A3 (en) Oxadiazoanthracene compounds for the treatment of diabetes
WO2011017350A3 (en) Compounds as lysophosphatidic acid receptor antagonists
WO2008007211A8 (en) Substituted n-bicyclicalkyl bicyclic carboxyamide compounds
WO2007135527A3 (en) Benzimidazolyl compounds
WO2010049454A3 (en) Antimicrobial composition from copepods
WO2008059370A3 (en) Substituted bicyclocarboxyamide compounds
WO2007136689A3 (en) Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
WO2008050199A3 (en) Substituted phenylmethyl bicyclocarboxyamide compounds
MX2010002171A (en) 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists.
TW200745003A (en) Novel compounds
WO2010049449A3 (en) Novel salts of sunitinib
WO2008098978A3 (en) Benzofuran compounds useful in the treatment of conditions mediated by the action of pge2 at the ep1 receptor
WO2010008735A3 (en) Solid states of o-desmethylvenlaf axine salts
ZA201107412B (en) Methods for the preparation of [2-8,9-dioxo2,6-diazabicyclo[5.2.0]non-1(1)-en-2-yl)ethyl]phosphonic acid and precursors thereof
WO2010079045A3 (en) Crystalline salt forms of flibanserine
ATE500226T1 (en) ARIPIPRAZOLE HEMIFUMARATE AND METHOD FOR THE PRODUCTION THEREOF
WO2009076408A3 (en) 3 -carboxypropyl-aminotetralin derivatives as mu opioid receptor antagonists
WO2010006904A3 (en) Crystalline forms of rabeprazole sodium
WO2007108011A3 (en) Process for the preparation of highly pure donepezil
WO2007125521A3 (en) Polymorphic form of zoledronic acid and processes for their preparation
MY179041A (en) Crystalline forms of a 3-carboxypropyl-aminotetralin compound
WO2009076399A3 (en) Aminotetralin compounds as mu opioid receptor antagonists